Researchers successfully used a noninvasive broadband optical spectroscopy (BOS) device to detect necrotizing enterocolitis (NEC) early in premature infants.
Key Details
- 1BOS is a handheld device that measures reflected infrared light from the intestines to detect early NEC.
- 2The technology distinguishes NEC from healthy tissue within two minutes at the bedside.
- 3First-in-human study tested BOS on 96 premature infants younger than 36 weeks gestation.
- 4BOS produced safe, feasible, and detectable signal changes in infants with NEC.
- 5BOS may identify NEC before it appears on x-ray; prior x-ray is the current standard diagnostic tool.
Why It Matters
BOS could allow bedside, early, radiation-free detection of NEC—a life-threatening disease—enabling earlier treatment and potentially improving outcomes in neonates. The move toward new optical imaging modalities may supplement or even precede conventional radiology tools like x-ray in this clinical scenario.
Source
EurekAlert
Related News
•EurekAlert
AI-Powered OCT Enables Rapid 'Optical Biopsy' for Early Endometrial Cancer Detection
A team at Washington University has developed a catheter-based 3D OCT system with AI to quickly and noninvasively detect early endometrial cancers.
•EurekAlert
AI Clinical Reasoning in Diagnostics and Digital Fatigue in Healthcare
Recent JMIR features explore large language models in clinical diagnostics and digital fatigue among healthcare professionals.
•EurekAlert
KAIST, MIT, Microsoft Develop Efficient AI Image Upsampling for Robotics
KAIST, MIT, and Microsoft have created 'Upsample Anything,' a training-free AI method to restore high-resolution visual data from compressed images with up to 16x improved GPU memory efficiency.